척추성형술 및 경피적풍선척추성형술용 바늘 시장 규모, 점유율, 동향 분석 보고서 : 시술별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Vertebroplasty And Kyphoplasty Needles Market Size, Share & Trends Analysis Report By Procedure (Kyphoplasty Procedures), By End Use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,515,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,946,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,809,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

척추성형술 및 경피적풍선척추성형술용 바늘 시장 성장과 동향

척추성형술 및 경피적풍선척추성형술용 바늘 세계 시장 규모는 2030년 12억 1,020만 달러에 달할 것으로 예상되며, 예측 기간 동안 4.9%의 CAGR로 성장할 것으로 예상됩니다. 척추 질환에 취약한 노년층의 증가와 그에 따른 위험성이 적은 최소침습적 시술에 대한 수요가 시장 성장을 견인하고 있습니다.

2018년 'Database of the National Spinal Cord Injury'에 따르면, 미국 내 척수 손상 사례의 6.0%가 새로운 척수 손상 사례로 보고되었으며, 그 중 38.0%가 자동차 사고로 인한 것이며, 8.0%가 스포츠 사고로 인한 것으로 나타났습니다.

척추 압박골절의 유병률은 나이가 들면서 증가하며, 골다공증의 가장 흔한 후유증 중 하나입니다. 미국에서는 매년 약 750만 건의 척추 압박골절이 새로 발생하며, 이로 인해 척추 골절 환자의 3분의 1 이상이 만성 통증이나 급성 통증을 경험하고 있습니다.

척추압박골절 환자는 일반적으로 심한 허리 통증을 경험하며, 이로 인해 운동에 제한을 받을 수 있습니다. 척척추성형술과 경피적풍선척추성형술은 척추체의 높이와 강도를 회복시키고 환자의 통증을 감소시키는데 성공하는 것으로 입증되었습니다. 이러한 수술은 최소침습적이며, 대규모 개복 척추 고정술에 비해 위험이 낮기 때문에 수요가 높습니다.

미국골대사학회는 척추성형술과 기타 척추압박골절 치료법의 안전성과 유효성에 대해 두 치료법의 안전성과 유효성에 대한 합의가 이루어지지 않아 태스크포스팀을 구성해 연구하고 있습니다.

척추성형술 및 경피적풍선척추성형술용 바늘 시장 보고서 하이라이트

• 2024년에는 경피적풍선척추성형술 부문이 60.4%로 가장 큰 비중을 차지했습니다. 경피적풍선척추성형술은 척추성형술의 고급 버전으로 기형을 줄이고 높이를 복원하며 골절을 안정화할 수 있으며 다른 시술보다 3배 더 일반적으로 시행됩니다.
• 최종 용도별로는 외래 수술 센터 부문이 현대식 의료 시설에 대한 수요 증가로 인해 가장 빠른 성장을 기록할 것으로 예상됩니다.
• 병원 부문은 2024년 59.7%의 점유율을 차지하며 시장을 지배했습니다. 척추 질환, 특히 골다공증의 유병률 증가가 병원 내 척추 성형술 및 골 성형술에 대한 수요를 주도하고 있습니다.
• 북미 척추성형술 및 경피적풍선척추성형술용 바늘 시장은 2024년 39.4%의 가장 큰 점유율을 차지했습니다. 이는 최소침습적 시술에 대한 수요 증가와 척추성형술 치료용 기기를 제공하는 많은 업체들이 진입하고 있기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 척추성형술 및 경피적풍선척추성형술용 바늘 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 산업 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 척추성형술 및 경피적풍선척추성형술용 바늘 시장 : 시술 비즈니스 분석

• 시술 시장 점유율, 2024년과 2030년
• 시술 부문 대시보드
• 시장 규모와 예측과 동향 분석, 시술별, 2018-2030년
• 경피적풍선척추성형술 시술
• 척추성형술 시술

제5장 척추성형술 및 경피적풍선척추성형술용 바늘 시장 : 최종 용도 비즈니스 분석

• 최종 용도 시장 점유율, 2024년과 2030년
• 최종 용도 부문 대시보드
• 시장 규모와 예측과 동향 분석, 최종 용도별, 2018-2030년
• 병원
• 외래 수술 센터

제6장 척추성형술 및 경피적풍선척추성형술용 바늘 시장 : 시술과 최종 용도에 의한 지역별, 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년과 2030년
• 지역별 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 구도

• 참여자 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요/상장 기업
  • Stryker
  • Medtronic
  • IZI Medical Products
  • Globus Medical
  • BPB medica-Biopsybell
  • Teknimed
  • Merit Medical Systems
  • ZAVATION
  • RONTIS

ksm

영문 목차

영문목차

Vertebroplasty And Kyphoplasty Needles Market Growth & Trends:

The global vertebroplasty and kyphoplasty needles market size is expected to reach USD 1,210.2 million in 2030 and is anticipated to grow at a CAGR of 4.9% over the forecast period. Increasing geriatric population prone to vertebral disorders and demand for minimally invasive procedures due to the fewer risks associated with them is boosting market growth.

Increase in incidence rates of injuries associated with adventure, sports, and accidents are also anticipated to boost market growth. As per the 2018, Database of the National Spinal Cord Injury, round 6.0% of new cases of spinal cord injury were reported in U.S. of which 38.0% were due to vehicle accidents and 8.0% due to sports injury.

The prevalence of vertebral compression fractures increases with age and is one of the most common sequelae of osteoporosis. There are around 7,50,000 new vertebral compression fractures every year in U.S. with resultant chronic and acute pain in over one-third of the patients with vertebral fractures.

Patients with VCFs generally experience severe back pain that may limit mobility. The vertebroplasty and balloon kyphoplasty procedures have been proven successful in restoring vertebral height and strength and are capable of reducing pain in patients. There is a high demand for the procedures as they are minimally invasive and possess low risks as compared to the larger open spinal fusion surgery.

The American Society for Bone and Mineral Research has established a Task Force to address the safety and efficacy of vertebral augmentation and other methods to treat the vertebral compression fractures as there is a lack of consent regarding the safety and efficacy of both medical procedures.

Vertebroplasty And Kyphoplasty Needles Market Report Highlights:

• The kyphoplasty procedures segment accounted for the largest share of 60.4% in 2024. Kyphoplasty is the advanced version of vertebroplasty and can reduce deformities, restore heights, and stabilize fractures and are three times more commonly performed than the other procedure
• Based on end-use, the ambulatory surgical center segment is anticipated to register the fastest growth due to the increasing demand for modern healthcare facilities
• The hospitals segment dominated the market with a share of 59.7% in 2024. The increasing prevalence of spinal disorders, particularly osteoporosis, is driving demand for vertebroplasty and kyphoplasty in hospitals.
• North America vertebroplasty and kyphoplasty needles market held the largest share of 39.4% in 2024. This is due to the rising demand for minimally invasive procedures as well as the presence of the large number of players that cater to the devices for the treatment of VCF.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Procedure
  • 1.2.2. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Vertebroplasty and Kyphoplasty Needles Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Vertebroplasty and Kyphoplasty Needles Market: Procedure Business Analysis

• 4.1. Procedure Market Share, 2024 & 2030
• 4.2. Procedure Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Procedure, 2018 to 2030 (USD Million)
• 4.4. Kyphoplasty Procedures
  • 4.4.1. Kyphoplasty procedures market, 2018 - 2030 (USD Million)
• 4.5. Vertebroplasty Procedures
  • 4.5.1. Vertebroplasty procedures market, 2018 - 2030 (USD Million)
  • 4.5.2. Directional Vertebroplasty Needles
    • 4.5.2.1. Directional vertebroplasty needles market, 2018 - 2030 (USD Million)
  • 4.5.3. Straight Vertebroplasty Needles
    • 4.5.3.1. Straight vertebroplasty needles market, 2018 - 2030 (USD Million)

Chapter 5. Vertebroplasty and Kyphoplasty Needles Market: End Use Business Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. End Use Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 5.4. Hospitals
  • 5.4.1. Hospitals market, 2018 - 2030 (USD Million)
• 5.5. Ambulatory Surgical Centers
  • 5.5.1. Ambulatory surgical centers market, 2018 - 2030 (USD Million)

Chapter 6. Vertebroplasty and Kyphoplasty Needles Market: Regional Estimates & Trend Analysis by Procedure and End Use

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key country dynamic
    • 6.4.2.2. Regulatory framework
    • 6.4.2.3. Competitive insights
    • 6.4.2.4. U.S. vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key country dynamic
    • 6.4.3.2. Regulatory framework
    • 6.4.3.3. Competitive insights
    • 6.4.3.4. Canada vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key country dynamic
    • 6.4.4.2. Regulatory framework
    • 6.4.4.3. Competitive insights
    • 6.4.4.4. Mexico vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key country dynamic
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive insights
    • 6.5.2.4. UK vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key country dynamic
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive insights
    • 6.5.3.4. Germany vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key country dynamic
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive insights
    • 6.5.4.4. France vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key country dynamic
    • 6.5.5.2. Regulatory framework
    • 6.5.5.3. Competitive insights
    • 6.5.5.4. Italy vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key country dynamic
    • 6.5.6.2. Regulatory framework
    • 6.5.6.3. Competitive insights
    • 6.5.6.4. Spain vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Denmark
    • 6.5.7.1. Key country dynamic
    • 6.5.7.2. Regulatory framework
    • 6.5.7.3. Competitive insights
    • 6.5.7.4. Denmark vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key country dynamic
    • 6.5.8.2. Regulatory framework
    • 6.5.8.3. Competitive insights
    • 6.5.8.4. Sweden vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Norway
    • 6.5.9.1. Key country dynamic
    • 6.5.9.2. Regulatory framework
    • 6.5.9.3. Competitive insights
    • 6.5.9.4. Norway vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key country dynamic
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive insights
    • 6.6.2.4. Japan vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key country dynamic
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive insights
    • 6.6.3.4. China vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key country dynamic
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive insights
    • 6.6.4.4. India vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. Australia
    • 6.6.5.1. Key country dynamic
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive insights
    • 6.6.5.4. Australia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. South Korea
    • 6.6.6.1. Key country dynamic
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive insights
    • 6.6.6.4. South Korea vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key country dynamic
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive insights
    • 6.6.7.4. Thailand vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key country dynamic
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive insights
    • 6.7.2.4. Brazil vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key country dynamic
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive insights
    • 6.7.3.4. Argentina vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key country dynamic
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive insights
    • 6.8.2.4. South Africa vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key country dynamic
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive insights
    • 6.8.3.4. Saudi Arabia vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key country dynamic
    • 6.8.4.2. Regulatory framework
    • 6.8.4.3. Competitive insights
    • 6.8.4.4. UAE vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key country dynamic
    • 6.8.5.2. Regulatory framework
    • 6.8.5.3. Competitive insights
    • 6.8.5.4. Kuwait vertebroplasty and kyphoplasty needles market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Stryker
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial performance
    • 7.5.1.3. Product benchmarking
    • 7.5.1.4. Strategic initiatives
  • 7.5.2. Medtronic
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial performance
    • 7.5.2.3. Product benchmarking
    • 7.5.2.4. Strategic initiatives
  • 7.5.3. IZI Medical Products
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial performance
    • 7.5.3.3. Product benchmarking
    • 7.5.3.4. Strategic initiatives
  • 7.5.4. Globus Medical
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial performance
    • 7.5.4.3. Product benchmarking
    • 7.5.4.4. Strategic initiatives
  • 7.5.5. BPB medica - Biopsybell
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial performance
    • 7.5.5.3. Product benchmarking
    • 7.5.5.4. Strategic initiatives
  • 7.5.6. Teknimed
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial performance
    • 7.5.6.3. Product benchmarking
    • 7.5.6.4. Strategic initiatives
  • 7.5.7. Merit Medical Systems
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial performance
    • 7.5.7.3. Product benchmarking
    • 7.5.7.4. Strategic initiatives
  • 7.5.8. ZAVATION
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial performance
    • 7.5.8.3. Product benchmarking
    • 7.5.8.4. Strategic initiatives
  • 7.5.9. RONTIS
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial performance
    • 7.5.9.3. Product benchmarking
    • 7.5.9.4. Strategic initiatives

관련자료